MESA LABORATORIES INC

NASDAQ: MLAB (Mesa Laboratories, Inc.)

Kemas kini terakhir: semalam, 9:42AM

133.60

-5.61 (-4.03%)

Penutupan Terdahulu 139.21
Jumlah Dagangan 24,768
Harga / Jualan (P/S) 3.07
Harga / Buku (P/B) 3.94
Julat 52 Minggu
69.51 (-47%) — 144.35 (8%)
Hasil Dividen (DY TTM) 0.48%
Margin Keuntungan -0.82%
Margin Operasi (TTM) 2.36%
EPS Cair (TTM) -0.360
Pertumbuhan Hasil Suku Tahunan (YOY) 5.50%
Jumlah Hutang/Ekuiti (D/E MRQ) 121.29%
Nisbah Semasa (MRQ) 0.630
Aliran Tunai Operasi (OCF TTM) 46.81 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 60.43 M
Pulangan Atas Aset (ROA TTM) 2.49%
Pulangan Atas Ekuiti (ROE TTM) -1.29%

AISkor Stockmoo

-0.6
Nilai 38% -1.7
AI Insight info NA
Penilaian Relatif info NA
Kesihatan Kewangan info -1.7
Masa 38% 0.2
AI Technical info NA
Osilator Teknikal info 2.0
Purata Bergerak Teknikal info -2.5
Sentimen 25% 0.4
Konsensus Penganalisis info 0.0
Sentimen Berita info 1.4
Wang Pintar NA
Aktiviti Orang Dalam info NA
Aliran Institusi info NA
Kedudukan Jual Singkat info NA
Persekitaran ×1.21
Persekitaran Makro info -3.3
Sektor berbanding Pasaran (6B) -20.1%
Persetujuan Tonggak ×1.00
Tidak dikira dalam skor
Volatiliti Harga info -5.0
Skor Akhir -0.55

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Scientific & Technical Instruments (US) Bercampur Menaik
Scientific & Technical Instruments (Global) Bercampur Menaik
Stok Mesa Laboratories, Inc. Bercampur Menaik

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
MLAB - 0.48% - 3.94
MIND - - - 0.700
FCUV - - - 0.280
WRAP - - - 5.19
SVRE - - - 0.370
ASTC - - - 0.520

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Sektor Technology
Industri Scientific & Technical Instruments
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 5.12%
% Dimiliki oleh Institusi 95.68%

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
12 Nov 2026 Yahoo Finance Sterilization Monitoring Technologies - Global Strategic Business Report 2026: Secure Share of the $1 Billion Market by 2032 | Features Competitive Intelligence on 3M, Steris, Getinge, Cardinal Health and Mesa Laboratories
Smart, wireless and cloud-based monitoring improves accuracy, automates compliance, reduces errors and streamlines sterilization workflows across healthcare settingsDublin, Nov. 12, 2026 (GLOBE NEWSWIRE) -- "Sterilization Monitoring Technologies - Global Strategic Business Report 2026" has been…
10 Nov 2026 Yahoo Finance Mesa Laboratories Inc (MLAB) Q2 2027 Earnings Call Highlights: Margin Expansion and ...
Mesa Laboratories Inc (MLAB) posted 2.6% organic revenue growth with adjusted EBITDA up 21.1%, while restructuring clinical genomics and resolving a key SDC product line remain top priorities.
09 Nov 2026 Yahoo Finance Mesa Labs Announces Second Quarter Fiscal Year 2027 Results and Issues First Full-Year Guidance
LAKEWOOD, Colo., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced results for its second fiscal quarter (“2Q27”) ended…
09 Nov 2026 Yahoo Finance Mesa Labs: Fiscal Q2 Earnings Snapshot
(MLAB) on Monday reported net income of $4.3 million in its fiscal second quarter.
09 Nov 2026 Yahoo Finance What Mesa Laboratories (MLAB) Said on Its Q2 Earnings Call
Mesa Laboratories (NASDAQ:MLAB) reported higher revenue and earnings for its fiscal 2027 second quarter and issued full-year guidance, while outlining plans to restructure its Clinical Genomics business and repurchase up to $40 million in shares. The company expects fiscal 2027 revenue of $250 mill…
09 Nov 2026 Yahoo Finance Mesa Labs (MLAB) Q2 2027 Earnings Call Transcript
Debt paydown and a new buyback shape a quarter with mixed segment results.
09 Nov 2026 Yahoo Finance Mesa Laboratories, Inc. Q2 2027 Earnings Call Summary
Moby summary of Mesa Laboratories, Inc.'s Q2 2027 earnings call…
28 Oct 2026 Yahoo Finance Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call
Lakewood, Colo., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced it will release financial results for its…
13 Oct 2026 Yahoo Finance Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth
The Restructuring Program focuses Clinical Genomics on profitability and adds resources in Sterilization and Disinfection Control, Calibration Solutions and AsiaLAKEWOOD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa,” “we,” “us” or “our”), a global leader…
09 Oct 2026 Yahoo Finance MESA LABS DECLARES QUARTERLY DIVIDEND
Lakewood, Colo., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15…
17 Aug 2026 Yahoo Finance Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript
CEO Kadia highlights execution fixes and debt reduction amid SDC fulfillment challenges.
Papar semua
Hasil Dividen (DY TTM) 0.48%
Purata Hasil Dividen 5T 0.50%
Nisbah Pembayaran 376.47%
Jangkaan Pembayaran Dividen Seterusnya Mar 2027
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
30 Nov 2026 08 Oct 2026 15 Dec 2026 0.16 Tunai
31 Aug 2026 06 Jul 2026 15 Sep 2026 0.16 Tunai
29 May 2026 02 Apr 2026 15 Jun 2026 0.16 Tunai
27 Feb 2026 06 Jan 2026 16 Mar 2026 0.16 Tunai
28 Nov 2025 03 Oct 2025 15 Dec 2025 0.16 Tunai
29 Aug 2025 03 Jul 2025 15 Sep 2025 0.16 Tunai
30 May 2025 07 Apr 2025 16 Jun 2025 0.16 Tunai
28 Feb 2025 06 Jan 2025 17 Mar 2025 0.16 Tunai
29 Nov 2024 02 Oct 2024 16 Dec 2024 0.16 Tunai
30 Aug 2024 08 Jul 2024 16 Sep 2024 0.16 Tunai
31 May 2024 02 Apr 2024 14 Jun 2024 0.16 Tunai
28 Feb 2024 02 Jan 2024 15 Mar 2024 0.16 Tunai
29 Nov 2023 02 Oct 2023 15 Dec 2023 0.16 Tunai
30 Aug 2023 05 Jul 2023 15 Sep 2023 0.16 Tunai
30 May 2023 03 Apr 2023 15 Jun 2023 0.16 Tunai
27 Feb 2023 03 Jan 2023 15 Mar 2023 0.16 Tunai
29 Nov 2022 03 Oct 2022 15 Dec 2022 0.16 Tunai
30 Aug 2022 06 Jul 2022 15 Sep 2022 0.16 Tunai
27 May 2022 04 Apr 2022 15 Jun 2022 0.16 Tunai
25 Feb 2022 05 Jan 2022 15 Mar 2022 0.16 Tunai
29 Nov 2021 01 Oct 2021 15 Dec 2021 0.16 Tunai
30 Aug 2021 06 Jul 2021 15 Sep 2021 0.16 Tunai
27 May 2021 05 Apr 2021 15 Jun 2021 0.16 Tunai
25 Feb 2021 04 Jan 2021 15 Mar 2021 0.16 Tunai
27 Nov 2020 01 Oct 2020 15 Dec 2020 0.16 Tunai
28 Aug 2020 03 Jul 2020 15 Sep 2020 0.16 Tunai
28 May 2020 01 Apr 2020 15 Jun 2020 0.16 Tunai
27 Feb 2020 08 Jan 2020 16 Mar 2020 0.16 Tunai
27 Nov 2019 01 Oct 2019 16 Dec 2019 0.16 Tunai
29 Aug 2019 08 Jul 2019 16 Sep 2019 0.16 Tunai
30 May 2019 08 Apr 2019 14 Jun 2019 0.16 Tunai
27 Feb 2019 02 Jan 2019 15 Mar 2019 0.16 Tunai
29 Nov 2018 01 Oct 2018 17 Dec 2018 0.16 Tunai
30 Aug 2018 05 Jul 2018 17 Sep 2018 0.16 Tunai
30 May 2018 03 Apr 2018 15 Jun 2018 0.16 Tunai
27 Feb 2018 02 Jan 2018 15 Mar 2018 0.16 Tunai
29 Nov 2017 02 Oct 2017 15 Dec 2017 0.16 Tunai
29 Aug 2017 05 Jul 2017 15 Sep 2017 0.16 Tunai
26 May 2017 05 Apr 2017 15 Jun 2017 0.16 Tunai
24 Feb 2017 03 Jan 2017 15 Mar 2017 0.16 Tunai
28 Nov 2016 03 Oct 2016 15 Dec 2016 0.16 Tunai
29 Aug 2016 05 Jul 2016 15 Sep 2016 0.16 Tunai
26 May 2016 11 Apr 2016 15 Jun 2016 0.16 Tunai
25 Feb 2016 05 Jan 2016 15 Mar 2016 0.16 Tunai
25 Nov 2015 01 Oct 2015 15 Dec 2015 0.16 Tunai
27 Aug 2015 07 Jul 2015 15 Sep 2015 0.16 Tunai
27 May 2015 01 Apr 2015 15 Jun 2015 0.16 Tunai
25 Feb 2015 06 Jan 2015 16 Mar 2015 0.16 Tunai
25 Nov 2014 02 Oct 2014 15 Dec 2014 0.16 Tunai
27 Aug 2014 16 Jul 2014 15 Sep 2014 0.15 Tunai
28 May 2014 23 Apr 2014 16 Jun 2014 0.15 Tunai
26 Feb 2014 31 Jan 2014 17 Mar 2014 0.15 Tunai
26 Nov 2013 31 Oct 2013 16 Dec 2013 0.15 Tunai
28 Aug 2013 05 Aug 2013 18 Sep 2013 0.14 Tunai
25 Feb 2013 05 Feb 2013 15 Mar 2013 0.14 Tunai
Papar semua

Hasil Dividen Tahunan

Tahun Dividen Tahunan ($) Kekerapan/Tahun Hasil %
2026 0.640 4 0.48
2025 0.640 4 0.82
2024 0.640 4 0.49
2023 0.640 4 0.61
2022 0.640 4 0.39
2021 0.640 4 0.20
2020 0.640 4 0.22
2019 0.640 4 0.26
2018 0.640 4 0.31
2017 0.640 4 0.52
2016 0.640 4 0.52
2015 0.640 4 0.64
2014 0.610 4 0.79
2013 0.430 3 0.55
Papar semua

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda